UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Haematologica (Roma), ISSN 0390-6078, 05/2007, Volume 92, Issue 5, pp. 612 - 618
Ph | ALL | Allogeneic transplantation | MRD | Adult ALL | Life Sciences & Biomedicine | Hematology | Science & Technology | Hematologic and hematopoietic diseases | Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy | Bone marrow, stem cells transplantation. Graft versus host reaction | Transfusions. Complications. Transfusion reactions. Cell and gene therapy | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Translocation, Genetic | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - pathology | Humans | Middle Aged | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - surgery | Male | Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Leukemia-Lymphoma, Adult T-Cell - drug therapy | Gene Deletion | Fusion Proteins, bcr-abl - blood | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - blood | Precursor Cell Lymphoblastic Leukemia-Lymphoma - blood | Basic Helix-Loop-Helix Transcription Factors - genetics | Hematopoietic Stem Cell Transplantation | Survival Rate | Combined Modality Therapy | Remission Induction | Adolescent | Survival Analysis | Oncogene Proteins, Fusion - blood | Kinetics | Transplantation Conditioning | Cohort Studies | Piperazines - administration & dosage | Clinical Trials as Topic - statistics & numerical data | Precursor Cell Lymphoblastic Leukemia-Lymphoma - surgery | Risk | Transplantation, Homologous | Neoplasm, Residual | Multicenter Studies as Topic | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - mortality | Polymerase Chain Reaction | Adult | Female | Myeloid-Lymphoid Leukemia Protein - blood | Gene Rearrangement, B-Lymphocyte | Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology | T-Cell Acute Lymphocytic Leukemia Protein 1 | Leukemia-Lymphoma, Adult T-Cell - genetics | Leukemia-Lymphoma, Adult T-Cell - surgery | Pyrimidines - administration & dosage | Gene Rearrangement, T-Lymphocyte | Leukemia-Lymphoma, Adult T-Cell - mortality | Kaplan-Meier Estimate | Proto-Oncogene Proteins - genetics | Treatment Outcome | Leukemia-Lymphoma, Adult T-Cell - pathology | Imatinib Mesylate | Biomarkers, Tumor - blood | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - genetics | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Leukemia-Lymphoma, Adult T-Cell - blood | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Benzamides | Index Medicus
Journal Article
Blood, ISSN 0006-4971, 04/2018, Volume 131, Issue 14, pp. 1522 - 1531
Life Sciences & Biomedicine | Hematology | Science & Technology | Recurrence | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - pathology | Humans | Middle Aged | Male | Survival Rate | Neoplasm, Residual | Disease-Free Survival | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Antibodies, Bispecific - adverse effects | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - mortality | Antibodies, Bispecific - administration & dosage | Adolescent | Adult | Female | Aged | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - blood | Index Medicus | Abridged Index Medicus | Clinical Trials and Observations
Journal Article
Blood, ISSN 0006-4971, 02/2007, Volume 109, Issue 3, pp. 926 - 935
Life Sciences & Biomedicine | Hematology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Prognosis | Humans | Child, Preschool | Infant | Male | Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality | Neoplasm, Residual | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - diagnosis | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - mortality | Classification | Adult | Female | Retrospective Studies | Cytogenetic Analysis | Child | Risk Assessment | Treatment Outcome | Precursor Cell Lymphoblastic Leukemia-Lymphoma - diagnosis | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - genetics | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Disease-Free Survival | Algorithms | Adolescent | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - classification | Biomarkers | Precursor Cell Lymphoblastic Leukemia-Lymphoma - classification | Index Medicus | Abridged Index Medicus | Clinical Trials and Observations
Journal Article
Cancer, ISSN 0008-543X, 01/2017, Volume 123, Issue 2, pp. 294 - 302
relapsed | refractory | inotuzumab | blinatumomab | minimal residual disease | acute lymphoblastic leukemia | Life Sciences & Biomedicine | Oncology | Science & Technology | Neoplasm, Residual - pathology | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - pathology | Humans | Middle Aged | Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality | Antineoplastic Agents - therapeutic use | Neoplasm Recurrence, Local - mortality | Neoplasm Recurrence, Local - pathology | Young Adult | Disease-Free Survival | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Stem Cell Transplantation - methods | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - mortality | Adolescent | Aged, 80 and over | Adult | Aged | B-Lymphocytes - pathology | Hematopoietic Stem Cell Transplantation - methods | Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology | Salvage Therapy - methods | Flow cytometry | Cell survival | Acute lymphatic leukemia | Leukemia | Minimal residual disease | Stem cell transplantation | Transplantation | Lymphatic leukemia | Patients | Survival | Doxorubicin | Vincristine | Cytometry | Cyclophosphamide | Salvage | Lymphocytes B | Stem cells | Remission | Adults | Cancer | Index Medicus | Abridged Index Medicus | Acute lymphoblastic leukemia
Journal Article
Blood, ISSN 0006-4971, 11/2013, Volume 122, Issue 19, pp. 3298 - 3307
Life Sciences & Biomedicine | Hematology | Science & Technology | GATA3 Transcription Factor - genetics | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - pathology | Age Factors | Exons | Humans | Middle Aged | Male | Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality | Genetic Loci | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - mortality | Female | B-Lymphocytes - pathology | Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology | Child | B-Lymphocytes - metabolism | Genetic Predisposition to Disease | Genome-Wide Association Study | Introns | Phosphotransferases (Alcohol Group Acceptor) - genetics | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - genetics | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Phenotype | Alleles | Survival Analysis | Polymorphism, Single Nucleotide | Chromosomes, Human, Pair 10 | Index Medicus | Abridged Index Medicus | Clinical Medicine | Hematologi | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
The New England journal of medicine, ISSN 0028-4793, 09/2014, Volume 371, Issue 11, pp. 1005 - 1015
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | General aspects | Medical sciences | Oligonucleotide Array Sequence Analysis | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - metabolism | Humans | Child, Preschool | Infant | Male | Young Adult | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Heterografts | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - mortality | Adult | Female | DNA, Neoplasm - analysis | Receptors, Cytokine - metabolism | Child | Philadelphia Chromosome | Receptors, Cytokine - genetics | Signal Transduction - genetics | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - genetics | Animals | Protein Kinase Inhibitors - therapeutic use | Adolescent | Survival Analysis | Mice | Polymorphism, Single Nucleotide | Genome, Human | Protein-Tyrosine Kinases - antagonists & inhibitors | Development and progression | Care and treatment | Genetic aspects | Research | Lymphocytic leukemia | Tyrosine metabolism | Cell proliferation | Tyk2 protein | Leukemia | Genes | Clinical trials | Oncology | Genomes | Kinases | Cell activation | Janus kinase 2 | Xenografts | Teenagers | Children | Adolescents | Protein-tyrosine kinase | Age | Tyrosine | Young adults | Genomic analysis | Acute lymphatic leukemia | Stat5 protein | Lymphatic leukemia | Gene expression | Philadelphia chromosome | Interleukin 7 receptors | Thymic stromal lymphopoietin | Lymphocytes B | Index Medicus | Abridged Index Medicus
Journal Article
Clinical cancer research, ISSN 1078-0432, 12/2018, Volume 24, Issue 24, pp. 6175 - 6184
Life Sciences & Biomedicine | Oncology | Science & Technology | Cell- and Tissue-Based Therapy - methods | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - pathology | Prognosis | Humans | Child, Preschool | Male | Receptors, Antigen, T-Cell | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - immunology | Young Adult | Immunity, Humoral | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - mortality | Adult | Female | Child | Antigens, CD19 - immunology | Immunotherapy, Adoptive - adverse effects | Immunotherapy, Adoptive - methods | Transgenes - genetics | Treatment Outcome | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - therapy | Animals | Adolescent | Lymphocyte Count | Mice | Cell- and Tissue-Based Therapy - adverse effects | Genetic Therapy - adverse effects | Genetic Therapy - methods | Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 03/2017, Volume 376, Issue 9, pp. 836 - 847
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Combined Modality Therapy | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - therapy | Transplantation, Homologous | Stem Cell Transplantation | Young Adult | Antibodies, Bispecific - therapeutic use | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Antibodies, Bispecific - adverse effects | Sepsis - chemically induced | Antineoplastic Agents - adverse effects | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - mortality | Adolescent | Survival Analysis | Aged, 80 and over | Adult | Female | Aged | Chemotherapy | Usage | Care and treatment | Acute lymphocytic leukemia | Diagnosis | Comparative analysis | Patients | Cancer | CD19 antigen | Acute lymphatic leukemia | Cell survival | Writers | Clinical trials | Stem cell transplantation | Lymphocytes T | CD3 antigen | Lymphatic leukemia | Lymphocytes B | Medical prognosis | Monoclonal antibodies | Remission | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 02/2018, Volume 378, Issue 5, pp. 439 - 448
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Humans | Receptors, Antigen, T-Cell - therapeutic use | Child, Preschool | Male | Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality | Receptors, Antigen, T-Cell - antagonists & inhibitors | Remission Induction | Young Adult | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Antibodies, Monoclonal, Humanized - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Survival Analysis | Antigens, CD19 | Female | Infusions, Intravenous | Child | Treatment outcome | Care and treatment | Young adults | Lymphocytic leukemia | Research | Children | Comparative analysis | Health aspects | Flow cytometry | Pediatrics | Edema | Medical research | CD19 antigen | Acute lymphatic leukemia | Transplants & implants | Hematology | Leukemia | Minimal residual disease | Oncology | Lymphocytes T | Lymphatic leukemia | Children & youth | Studies | Chimeric antigen receptors | Lymphocytes B | Stem cells | Bone marrow | Remission | Cancer | Index Medicus | Abridged Index Medicus
Journal Article